Capital Impact Advisors, LLC Omeros Corp Transaction History

Capital Impact Advisors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$9.03 - $19.72 $1.18 Million - $2.57 Million	-130,187 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$13.01 - $17.15 $317,079 - $417,979	24,372 Added 23.03%	130,187 $1.83 Million
Q3 2019 Nov 14, 2019	SELL	$14.55 - $20.56 $61,983 - $87,585	-4,260 Reduced 3.87%	105,815 $1.74 Million
Q2 2019 Jul 19, 2019	SELL	$15.0 - $19.62 $397,425 - $519,831	-26,495 Reduced 19.4%	110,075 $1.7 Million
Q4 2018 Mar 08, 2019	BUY	$10.72 - $16.73 $437,536 - $682,834	40,815 Added 42.62%	136,570 $1.58 Million
Q1 2018 Apr 11, 2018	BUY	$9.0 - $20.16 $292,761 - $655,784	32,529 Added 51.45%	95,755 $1.07 Million
Q3 2017 Jan 16, 2018	BUY	$19.76 - $24.9 $1.25 Million - $1.57 Million	63,226	63,226 $1.37 Million

120

25.6M

228K

630K

Ticker OMER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,730,000
Market Cap $762M
Description
Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...

Get notified when there are updates to the investment portfolio of Capital Impact Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Capital Impact Advisors, LLC with notifications on news.